SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

November 20, 2009 | 
1 min read
Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
Capricor Plunges on FDA Rejection of DMD Cell Therapy
July 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Person buried in paperwork hand raised collage art. Man drown in work concept. Overwork illustration for news banner, web articles, and posters
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
 · 
5 min read
 · 
Annalee Armstrong
Complete response letters
FDA Publishes Cache of Complete Response Letters in Bid for ‘Radical Transparency’
July 10, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Government
Kennedy Postpones Preventive Care Panel Meeting After ‘Double-Edged Sword’ Supreme Court Win
July 10, 2025
 · 
2 min read
 · 
Tristan Manalac